NervGen Pharma Corp (NGEN : TSX-V)
Common Stock
$5.15
CAD
+0.00 (%)
Last updated: 2026-03-17
Get NGEN alerts:
NGEN
NervGen Pharma Corp
WealthAwesomePerformance
1 Day
+0.00%
1 Week
+0.00%
1 Month
+0.00%
YTD
-35.06%
Key Statistics
Market Cap
$407.94M
52W High
$8.49
52W Low
$2.57
P/E Ratio
-
50 Day MA
$6.19
200 Day MA
$4.60
Beta
0.86
Dividend Yield
-
Advertisement
NervGen Pharma Corp insider transactions
Open-market and private equity trades (last 12 months volume). Derivatives and opening balances excluded.
Recent transactions
| Date | Side | Name | Shares | Price |
|---|---|---|---|---|
| May 27, 26 | Buy | Ruffolo, John Individual · CA$33 | 16 | CA$2.08 |
| May 27, 26 | Buy | Ruffolo, John Individual · CA$18,234 | 8,775 | CA$2.08 |
| May 27, 26 | Buy | Ruffolo, John Individual · CA$18,234 | 8,775 | CA$2.08 |
| May 26, 26 | Buy | Rogers, Adam Individual · CA$2.0m | 800,000 | CA$2.50 |
| May 26, 26 | Buy | Rogers, Adam Individual · CA$2.9m | 800,000 | CA$3.68 |
| Apr 29, 26 | Buy | Punnett, Harold Individual · CA$15,912 | 4,250 | CA$3.74 |
| Apr 08, 26 | Sell | McKerracher, Krista Individual · CA$41,914 | 10,000 | CA$4.19 |
| Apr 02, 26 | Sell | McKerracher, Krista Individual · CA$21,150 | 5,000 | CA$4.23 |
| Mar 09, 26 | Sell | McKerracher, Krista Individual · CA$19,924 | 5,000 | CA$3.98 |
| Mar 02, 26 | Sell | McKerracher, Krista Individual · CA$38,517 | 10,000 | CA$3.85 |
Technical Indicators
Price vs 50-Day SMA
Price vs 200-Day SMA
Recent Price History
| Date | Open | High | Low | Close | Adj Close | Volume |
|---|---|---|---|---|---|---|
| 3/17/2026 | $5.15 | $5.15 | $5.15 | $5.15 | $5.15 | 0 |
| 3/16/2026 | $4.95 | $5.23 | $4.93 | $5.15 | $5.15 | 66,939 |
| 3/13/2026 | $5.20 | $5.30 | $4.87 | $5.00 | $5.00 | 114,157 |
| 3/12/2026 | $5.34 | $5.38 | $5.20 | $5.26 | $5.26 | 37,210 |
| 3/11/2026 | $5.50 | $5.50 | $5.29 | $5.35 | $5.35 | 42,945 |
| 3/10/2026 | $5.55 | $5.70 | $5.45 | $5.50 | $5.50 | 34,365 |
| 3/9/2026 | $5.46 | $5.63 | $5.35 | $5.61 | $5.61 | 35,823 |
| 3/6/2026 | $5.50 | $5.56 | $5.42 | $5.46 | $5.46 | 32,955 |
| 3/5/2026 | $5.85 | $5.85 | $5.45 | $5.53 | $5.53 | 67,514 |
| 3/4/2026 | $5.45 | $5.93 | $5.45 | $5.89 | $5.89 | 40,846 |
Analyst Price Targets
Based on analyst covering NGEN
Wall Street analysts forecast NGEN stock price to rise 45.3% over the next 12 months.
Consensus
BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$7.48
+45.3% Upside
Current Price
C$5.15
Last close
Analyst ratings and price targets are updated periodically. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on NGEN's historical volatility
30-Day Vol
61.5%
Annualized
90-Day Vol
82.6%
Annualized
Trend (90d)
-50.0%
Annualized drift
90d Mean
C$4.31
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$4.85 | C$3.92 – C$6.00 |
| 60 trading days | C$4.57 | C$3.39 – C$6.17 |
| 90 trading days | C$4.31 | C$2.98 – C$6.22 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
About NervGen Pharma Corp
NervGen Pharma Corp., a biotechnology company, engages in the discovery, development, and commercialization of pharmaceutical treatments to promote nervous system repair in settings of neurotrauma and neurologic disease. The company's lead product candidate is NVG-291 that is in Phase 1b/2a clinical trial for the treatment of spinal cord injuries (SCI), stroke, multiple sclerosis, and Alzheimer's disease; and NVG-300, which is in a preclinical model of ischemic stroke and confirmatory SCI study. NervGen Pharma Corp. has a licensing agreement with Case Western Reserve University to develop and commercialize a patented technology with therapeutic potential for spinal cord injury and other conditions associated with nerve damage. The company was incorporated in 2017 and is based in Vancouver, Canada.
Financials
- Revenue (TTM)
- $0
- EBITDA
- $-25.20M
- Profit Margin
- 0.00%
- ROE (TTM)
- -820.11%
- EPS (Diluted)
- -0.36
- Book Value
- -0.04
Classification
- Sector
- Health Care
- Industry
- Biotechnology
- Group
- Pharmaceuticals, Biotechnology & Life Sciences
7 stocks to buy and hold forever
Blue-chip dividend stocks for long-term wealth building.
Get the FREE ReportExplore More
Advertisement
Common Questions About NGEN
Market movers
Recent TSX-V movers
Top 1-day gainers — updated from our Canadian movers feed.
| Ticker | Name | Price | 1D |
|---|---|---|---|
| BIGT | Big Tree Carbon Inc. | $0.02 | +100.00% |
| CSTR | CryptoStar Corp | $0.01 | +100.00% |
| MAN-P | Mandala Capital Inc. | $0.06 | +100.00% |
| NOB | Noble Mineral Exploration Inc | $0.09 | +70.00% |
| FRNT | FRNT Financial Inc | $0.10 | +33.33% |
| BECN | BEACN Wizardry & Magic Inc | $0.04 | +33.33% |
| PPM | Pacific Imperial Mines Inc | $0.02 | +33.33% |
| BIG | Hercules Metals Corp. | $0.77 | +30.51% |
NGEN.V news timeline
1 article covering NGEN.V, most recent first
Latest